SICAGEN INDIA LIMITED

25.8 +1.26 (+4.88%) Buy

Sun shines over SICAGEN investors as it outperforms broader market

13 min read

SICAGEN INDIA LIMITED outperformed the broader market today. It increased by +4.88% to close at 25.8. It's recent 5 day performance has been +0.41%, -1.8%, -0.2%, 0.0% and -3.66%.

[Themes containing SICAGEN]

SICAGEN is currently in a bullish trend. Over the last three months Buy-and-Hold has been a better strategy (returning +4.88%) for SICAGEN's investors than trading long signals.

Trend

SICAGEN has been outperforming the NIFTY-50 index in recent time. It showed significant outperformance (compared to the NIFTY-50 index) from 2 Jun, 2016 to 10 Jan, 2018. Over the last 3 years and 1 month, SICAGEN outperformed the NIFTY-50 index on 42% days. Which indicates that on days SICAGEN outperforms the NIFTY-50 index, it's performance is marginally better than on the days it underperforms the NIFTY-50 index.

During the last three months SICAGEN delivered losses on 56% days. However, it still managed to end this period in a profit. It's best return during this period (of +5.83%) was on Wednesday, 12 Dec, 2018. While it's worst loss in the same period (of -9.73%) was on Tuesday, 23 Oct, 2018. The longest stort-term trend during this period was 7 losing days, which started on 30 Nov, 2018 and ended on 10 Dec, 2018. This bearish trend lost -12.79% of investor capital.

During the last year SICAGEN had 5 profitable months and 7 loss making months. Profitable number of months of SICAGEN and NIFTY-50 index were the same. SICAGEN was also a more risky investment than NIFTY-50 index as it's worst month in the last year, Jun 2018, returned -19.33% compared to -6.42% returned by NIFTY-50 index in Sep 2018. SICAGEN had a longer winning streak of profitable months than NIFTY-50 index. It went up in 3 straight months (from Nov 2018 to Jan 2019) during which period it delivered +9.62%. It is interesting to note that both SICAGEN and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

My old father used to have a saying: If you make a bad bargain, hug it all the tighter.
-- Abraham Lincoln

SICAGEN is currently seeing overall increase in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in SICAGEN's volatility from 23 Oct, 2018 to 7 Dec, 2018. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that SICAGEN has significant negative skewness in it's return distribution. This indicates that SICAGEN is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than SICAGEN. Therefore, NIFTY-50 must receive a lower allocation than SICAGEN in your portfolio. NIFTY-50 index usually has shorter drawdown period than SICAGEN.

Based on your interest in SICAGEN you may find it interesting to know that LTTS, CUB and LTI are mid caps that have all shown remarkable performance and qualify to be on every investor's watchlist.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter